Nuzenio

Abcellera

Abcellera news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 23 latest news signals 14 publisher sources 100/100 entity strength

Latest news

Timeline

Sat, 08 Aug 2026 14:45:00 GMTAbCellera (NASDAQ:ABCL) Shares Surge Ahead of Monday's ABCL635 Phase 2 Trial Results - TechStock²
Sat, 08 Aug 2026 02:26:46 GMTAbCellera Biologics | 8-K: Current report - Moomoo
Fri, 07 Aug 2026 23:36:50 GMTStocks to Watch: AbCellera - Moomoo
Fri, 07 Aug 2026 21:05:58 GMT12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Fri, 07 Aug 2026 20:53:02 GMTAbCellera to Release Phase 2 Top-Line Results for ABCL635 and Host Investor Call Aug 10 - TradingView
Fri, 07 Aug 2026 20:30:00 GMTAbCellera to Announce Top-Line Results from the Phase 2 Trial of ABCL635 for the Treatment of Moderate-to-Severe VMS Due to Menopause on Monday, August 10, 2026 - Business Wire

Related explainers

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Abcellera.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

14 distinct publisher/source names are currently connected to this entity page.